Summary & Overview
CPT 81431: Genomic Sequencing for Hearing Loss Duplication/Deletion Analysis
CPT code 81431 represents a genomic sequencing procedure focused on the analysis of duplications and deletions associated with hearing loss. This advanced molecular assay is increasingly important in the diagnosis and management of hereditary hearing conditions, offering clinicians precise genetic information to inform patient care. The code is typically billed from laboratory settings, reflecting the specialized nature of the testing.
Major national payers, including Aetna, Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare, are covered in this analysis. Readers will gain insight into payer coverage trends, relevant policy updates, and clinical benchmarks for the use of 81431. The publication also provides context on related codes, such as those for CFTR gene analysis and unlisted molecular pathology procedures, and outlines common modifiers used in billing. Additionally, the summary includes associated taxonomies and ICD-10 diagnoses relevant to hearing loss and genetic screening.
This article offers a comprehensive overview of 81431, equipping stakeholders with the latest information on payer coverage, clinical applications, and billing practices for genomic sequencing procedures targeting hearing loss.
CPT Code Overview
CPT code 81431 is used to report genomic sequencing procedures specifically for hearing loss duplication and deletion analysis. This code falls under Genomic Sequencing Procedures and Other Molecular Multianalyte Assays, reflecting advanced molecular diagnostic testing. The typical site of service for this procedure is a laboratory (POS 81), where specialized genetic testing is performed to identify genetic causes of hearing loss. This testing supports clinical decision-making by providing detailed genetic information relevant to patient care.
Clinical & Coding Specifications
Clinical Context
A patient, often a child or young adult, presents with symptoms of hearing loss. The clinician suspects a genetic etiology, particularly involving gene duplications or deletions associated with hearing impairment. The patient may also have a family history of cystic fibrosis or other genetic disorders. The provider orders genomic sequencing procedures, specifically the hearing loss duplication/deletion analysis (CPT 81431), to identify potential genetic causes. The specimen is sent to a laboratory (POS 81) specializing in molecular genetics. Results are interpreted by a medical geneticist or a Ph.D. in medical genetics, and findings may inform further management or genetic counseling.
Coding Specifications
-
Modifiers:
26: Professional Component – Used when only the interpretation of the test is performed, not the technical aspect.TC: Technical Component – Used when only the technical performance of the test (e.g., running the assay in the lab) is billed.
-
Provider Taxonomies:
| Taxonomy Code | Specialty Name |
|---|